|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/138 | (2006.01) |
| A61K 31/17 | (2006.01) | ||
| A61K 31/282 | (2006.01) | ||
| A61K 31/352 | (2006.01) | ||
| A61K 31/4535 | (2006.01) | ||
| A61K 31/53 | (2006.01) | ||
| A61K 31/185 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 25/04 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3213748 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16201983.0 |
| Date of filing the European patent application | 2009-06-04 | |
| (97) | Date of publication of the European application | 2017-09-06 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-18 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 0810203 | 2008-06-04 | GB |
| (72) |
VELASCO DIEZ, Guillermo , ES
GUZMAN PASTOR, Manuel , ES
LORENTE, Mar , ES
TORRES, Sofia , ES
|
| (73) |
GW Pharma Limited ,
Sovereign House, Histon
Cambridge CB24 9BZ,
GB
|
| (54) | CANNABINOIDS (THC:CBD RATIO) IN COMBINATION WITH AN ALKYLATING AGENT FOR USE IN TREATING BRAIN TUMOUR |
| CANNABINOIDS (THC:CBD RATIO) IN COMBINATION WITH AN ALKYLATING AGENT FOR USE IN TREATING BRAIN TUMOUR |